Recommendation to grant GTC Biotherapeutics request

First Page		Document Content
Medicine Antithrombin Biotechnology Pharmacology Pulmonary embolism Thrombus Recombinant DNA Thrombin Biologic Biology Blood Coagulation system		Recommendation to grant GTC Biotherapeutics request Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 34,69 KB Share Document on Facebook

	Biomolecular Interaction and The Interactome.doc DocID: 1pQMx - View Document
	Domestic Sales Outsourcing Agreement for Recombinant Human Antithrombin Preparation Signed Tokyo, Japan, July 30, The Japan Blood Products Organization (head office: Tokyo, Japan, President and representative di DocID: 1lLMs - View Document
	Paris, 19 MayPress releaseGTC BIOTHERAPEUTICS Inc., a LFB group company, granted protection until 2027 on broad transgenic protein production patent, and is also granted new patent on recombinant antithrombin pro DocID: 1aPBm - View Document
	Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen DocID: 1aOgJ - View Document
	HAEMATOLOGIC TECHNOLOGIES INCResearch Reagents Catalog DocID: 1apfC - View Document